...
首页> 外文期刊>Vascular >Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.
【24h】

Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures.

机译:血管内治疗是严重肢体缺血患者进行肢体抢救的主要方法:443例fra下手术经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endovascular strategies for the treatment of critical infrageniculate peripheral arterial occlusive disease exist and are becoming the primary methodology for such lesions at many centers. Although technically feasible for experienced operators, the evidence to support this strategy for below the knee (BTK) interventions is still evolving. We studied the 6-month and 1-year outcomes of percutaneous transluminal angioplasty (PTA) alone, PTA with stenting, and excimer laser recanalization for BTK lesions in patients with critical limb ischemia. Between September 2002 and June 2005, 443 patients (355 Rutherford category 4, 82 category 5, 6 category 6) underwent intervention for 681 BTK lesions. Follow-up was performed at 6-month intervals after index intervention: limb salvage data were recorded and duplex ultrasonography was performed to measure the patency of treated areas. The primary patency and limb salvage rates of the entire population were 85.2% and 97.0% and 74.2% and 96.6% at 6 months and 1 year,respectively. Stratified for the treatment strategy (PTA alone in 79, PTA with stenting in 300 patients, and excimer laser in 64), 1-year primary patency rates were 68.6%, 75.5%, and 75.4%, whereas the limb salvage rates were 96.7%, 98.6%, and 87.9% for each modality, respectively. Endovascular intervention will become the primary treatment for BTK lesions in patients with critical limb ischemia, with 1-year primary patency and limb salvage rates that compare favorably with published surgical data. Prospective, randomized, multicenter trials will be needed to further establish the role of endovascular intervention in this challenging patient group.
机译:存在用于治疗严重的下脚形外周动脉闭塞性疾病的血管内策略,并且正在成为许多中心治疗此类病变的主要方法。尽管对于经验丰富的操作员来说在技术上是可行的,但仍在不断发展支持膝盖以下(BTK)干预策略的证据。我们研究了严重肢体缺血患者的经皮腔内血管成形术(PTA),PTA支架置入和准分子激光再通治疗BTK病变的6个月和1年结果。在2002年9月至2005年6月之间,对443例患者(355卢瑟福的4类,82类的5类,6类的6类患者)进行了681例BTK病变的干预。指数干预后每6个月进行一次随访:记录肢体抢救数据,并进行双程超声检查以测量治疗区域的通畅性。整个人群在6个月和1年的初次通畅率和肢体抢救率分别为85.2%和97.0%,74.2%和96.6%。根据治疗策略进行分层(仅PTA 79例,带支架的PTA 300例,准分子激光64例),一年原发通畅率分别为68.6%,75.5%和75.4%,而肢体抢救率则为96.7%。 ,每种方式分别为98.6%和87.9%。血管内介入治疗将成为严重肢体缺血患者BTK病变的主要治疗方法,其一年的通畅率和肢体抢救率与已发表的外科手术数据相比具有优势。需要进一步的前瞻性,随机,多中心试验来进一步确定血管内介入治疗在这一具有挑战性的患者群体中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号